Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 36; no. 15_suppl; p. 4074
Main Authors Stein, Stacey, Pishvaian, Michael J., Lee, Michael Sangmin, Lee, Kyung-Hun, Hernandez, Sairy, Kwan, Antonia, Liu, Bo, Grossman, William, Iizuka, Koho, Ryoo, Baek-Yeol
Format Journal Article
LanguageEnglish
Published 20.05.2018
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.4074